Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that have limited their business in the country in response to its invasion of Ukraine.
J&J said it would continue to supply medicines and medical devices in the region as those are excluded from Western sanctions. It will, however, not enroll more patients in clinical drug trials it was running in Russia, it said earlier.
